BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 12800197)

  • 1. Homozygous deletions scanning in tumor cell lines detects previously unsuspected loci.
    Pineau P; Marchio A; Cordina E; Tiollais P; Dejean A
    Int J Cancer; 2003 Aug; 106(2):216-23. PubMed ID: 12800197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homozygous deletion scanning in hepatobiliary tumor cell lines reveals alternative pathways for liver carcinogenesis.
    Pineau P; Marchio A; Nagamori S; Seki S; Tiollais P; Dejean A
    Hepatology; 2003 Apr; 37(4):852-61. PubMed ID: 12668978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.
    Thompson PM; Maris JM; Hogarty MD; Seeger RC; Reynolds CP; Brodeur GM; White PS
    Cancer Res; 2001 Jan; 61(2):679-86. PubMed ID: 11212268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
    Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
    Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR.
    Berggren P; Kumar R; Sakano S; Hemminki L; Wada T; Steineck G; Adolfsson J; Larsson P; Norming U; Wijkström H; Hemminki K
    Clin Cancer Res; 2003 Jan; 9(1):235-42. PubMed ID: 12538475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.
    Gorringe KL; Ramakrishna M; Williams LH; Sridhar A; Boyle SE; Bearfoot JL; Li J; Anglesio MS; Campbell IG
    Genes Chromosomes Cancer; 2009 Oct; 48(10):931-42. PubMed ID: 19603523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis.
    Toomes C; Jackson A; Maguire K; Wood J; Gollin S; Ishwad C; Paterson I; Prime S; Parkinson K; Bell S; Woods G; Markham A; Oliver R; Woodward R; Sloan P; Dixon M; Read A; Thakker N
    Genes Chromosomes Cancer; 2003 Jun; 37(2):132-40. PubMed ID: 12696061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI; Minna JD
    Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of homozygous deletions in verified esophageal adenocarcinoma cell lines and xenografts.
    Boonstra JJ; van Marion R; Douben HJ; Lanchbury JS; Timms KM; Abkevich V; Tilanus HW; de Klein A; Dinjens WN
    Genes Chromosomes Cancer; 2012 Mar; 51(3):272-82. PubMed ID: 22081516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative real-time PCR does not show selective targeting of p14(ARF) but concomitant inactivation of both p16(INK4A) and p14(ARF) in 105 human primary gliomas.
    Labuhn M; Jones G; Speel EJ; Maier D; Zweifel C; Gratzl O; Van Meir EG; Hegi ME; Merlo A
    Oncogene; 2001 Mar; 20(9):1103-9. PubMed ID: 11314047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
    Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
    Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying novel homozygous deletions by microsatellite analysis and characterization of tumor suppressor candidate 1 gene, TUSC1, on chromosome 9p in human lung cancer.
    Shan Z; Parker T; Wiest JS
    Oncogene; 2004 Aug; 23(39):6612-20. PubMed ID: 15208665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene.
    Wiest JS; Franklin WA; Otstot JT; Forbey K; Varella-Garcia M; Rao K; Drabkin H; Gemmill R; Ahrent S; Sidransky D; Saccomanno G; Fountain JW; Anderson MW
    Cancer Res; 1997 Jan; 57(1):1-6. PubMed ID: 8988029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
    Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
    Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequently deleted loci on chromosome 9 may harbor several tumor suppressor genes in human renal cell carcinoma.
    Grady B; Goharderakhshan R; Chang J; Ribeiro-Filho LA; Perinchery G; Franks J; Presti J; Carroll P; Dahiya R
    J Urol; 2001 Sep; 166(3):1088-92. PubMed ID: 11490304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
    Pollock PM; Welch J; Hayward NK
    Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma.
    Tannapfel A; Sommerer F; Benicke M; Weinans L; Katalinic A; Geissler F; Uhlmann D; Hauss J; Wittekind C
    J Pathol; 2002 Aug; 197(5):624-31. PubMed ID: 12210082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical [corrected] detection of the alternate INK4a-encoded tumor suppressor protein p14(ARF) in archival human cancers and cell lines using commercial antibodies: correlation with p16(INK4a) expression.
    Geradts J; Wilentz RE; Roberts H
    Mod Pathol; 2001 Nov; 14(11):1162-8. PubMed ID: 11706079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas.
    Senchenko VN; Liu J; Loginov W; Bazov I; Angeloni D; Seryogin Y; Ermilova V; Kazubskaya T; Garkavtseva R; Zabarovska VI; Kashuba VI; Kisselev LL; Minna JD; Lerman MI; Klein G; Braga EA; Zabarovsky ER
    Oncogene; 2004 Jul; 23(34):5719-28. PubMed ID: 15208675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.